Ember LifeSciences initially launched as an offshoot of Ember Technologies' 'Ember,' the design-led temperature control brand and maker of the award-winning temperature control mug, which has surpassed half a billion dollars in total sales to date. Ember LifeSciences seeks to redefine global medicine distribution through leveraging Ember's proprietary temperature control technology to improve the way we transport life-saving medicines and vaccines around the world.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/16/25 | $16,500,000 | Series A |
Cardinal Health Carrier Ventures Sea Court Capital  | undisclosed |
